Genome-wide analysis of alternative splicing in medulloblastoma identifies splicing patterns characteristic of normal cerebellar development

Cancer Research

Volumn 71, Issue 6, 2011, Pages 2045-2055

  Menghi, Francesca ^a   Jacques, Thomas S ^a,b   Barenco, Martino ^a   Schwalbe, Ed C ^c   Clifford, Steven C ^c   Hubank, Mike ^a   Ham, Jonathan ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SONIC HEDGEHOG PROTEIN;

ADULT; AGE DISTRIBUTION; ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN DEVELOPMENT; CEREBELLAR GRANULE CELL PRECURSOR; CEREBELLUM; CHILD; CONTROLLED STUDY; DEVELOPMENTAL STAGE; FETUS; FETUS DEVELOPMENT; GENE CASSETTE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENOME ANALYSIS; GRANULE CELL; HUMAN; HUMAN TISSUE; MEDULLOBLASTOMA; MOLECULAR GENETICS; MOUSE; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; STEM CELL;

ALTERNATIVE SPLICING; ANIMALS; CELL LINE, TUMOR; CELLS, CULTURED; CEREBELLAR NEOPLASMS; CEREBELLUM; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME; GENOME-WIDE ASSOCIATION STUDY; HEK293 CELLS; HUMANS; MEDULLOBLASTOMA; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79952753928     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-2519     Document Type: Article

References (50)

1. Crawford JR, MacDonald TJ, Packer RJ. Medulloblastoma in childhood: new biological advances. Lancet Neurol 2007;6:1073-85. (Pubitemid 350116703)
2. Packer RJ, Gurney JG, Punyko JA, Donaldson SS, Inskip PD, Stovall M, et al. Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study. J Clin Oncol 2003;21:3255-61. (Pubitemid 46606258)
3. Kool M, Koster J, Bunt J, Hasselt NE, Lakeman A, van Sluis P, et al. Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One 2008;3:e3088.
4. Thompson MC, Fuller C, Hogg TL, Dalton J, Finkelstein D, Lau CC, et al. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol 2006;24:1924-31. (Pubitemid 46638992)
5. Johnson JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, Armour CD, et al. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 2003;302:2141-4. (Pubitemid 38017950)
6. Clark TA, Schweitzer AC, Chen TX, Staples MK, Lu G, Wang H, et al. Discovery of tissue-specific exons using comprehensive human exon microarrays. Genome Biol 2007;8:R64.
7. Dutertre M, Lacroix-Triki M, Driouch K, de la Grange P, Gratadou L, Beck S, et al. Exon-based clustering of murine breast tumor transcriptomes reveals alternative exons whose expression is associated with metastasis. Cancer Res 2010;70:896-905.
8. French PJ, Peeters J, Horsman S, Duijm E, Siccama I, Van Den Bent MJ, et al. Identification of differentially regulated splice variants and novel exons in glial brain tumors using exon expression arrays. Cancer Res 2007;67:5635-42. (Pubitemid 46984994)
9. Gardina PJ, Clark TA, Shimada B, Staples MK, Yang Q, Veitch J, et al. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array. BMC Genomics 2006;7:325.
10. David CJ, Manley JL. Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev 2010;24:2343-64.
11. Pajares MJ, Ezponda T, Catena R, Calvo A, Pio R, Montuenga LM. Alternative splicing: an emerging topic in molecular and clinical oncology. Lancet Oncol 2007;8:349-57. (Pubitemid 46464532)
12. Ferretti E, Di Marcotullio L, Gessi M, Mattei T, Greco A, Po A, et al. Alternative splicing of the ErbB-4 cytoplasmic domain and its regulation by hedgehog signaling identify distinct medulloblastoma subsets. Oncogene 2006;25:7267-73. (Pubitemid 44809092)
13. Glassmann A, Molly S, Surchev L, Nazwar TA, Holst M, Hartmann W, et al. Developmental expression and differentiation-related neuronspecific splicing of metastasis suppressor 1 (Mtss1) in normal and transformed cerebellar cells. BMC Dev Biol 2007;7:111.
14. Li XN, Shu Q, Su JM, Adesina AM, Wong KK, Perlaky L, et al. Differential expression of survivin splice isoforms in medulloblastomas. Neuropathol Appl Neurobiol 2007;33:67-76. (Pubitemid 46090311)
15. Read TA, Hegedus B, Wechsler-Reya R, Gutmann DH. The neurobiology of neurooncology. Ann Neurol 2006;60:3-11.
16. Eberhart CG, Kepner JL, Goldthwaite PT, Kun LE, Duffner PK, Friedman HS, et al. Histopathologic grading of medulloblastomas: a pediatric oncology group study. Cancer 2002;94:552-60. (Pubitemid 34081387)
17. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97-109. (Pubitemid 47103521)
18. Shah SH, Pallas JA. Identifying differential exon splicing using linear models and correlation coefficients. BMC Bioinformatics 2009;10:26.
19. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003;31:e15.
20. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004;3. Article 3.
21. Bemmo A, Benovoy D, Kwan T, Gaffney DJ, Jensen RV, Majewski J. Gene expression and isoform variation analysis using Affymetrix Exon arrays. BMC Genomics 2008;9:529.
22. Whistler T, Chiang CF, Lin JM, Lonergan W, Reeves WC. The comparison of different pre- and post-analysis filters for determination of exon-level alternative splicing events using Affymetrix arrays. J Biomol Tech 2010;21:44-53.
23. Affymetrix technical note. Identifying and validating alternative splicing events: an introduction to managing data provided by GeneChip Exon Arrays [cited 2010 Nov 9]. Available from: http://media.affymetrix.com/support/ technical/technotes/id-altsplicingevents-technote.pdf.
24. Yates T, Okoniewski MJ, Miller CJ. X:Map: annotation and visualization of genome structure for Affymetrix exon array analysis. Nucleic Acids Res 2008;36:D780-6.
25. Wechsler-Reya RJ, Scott MP. Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog. Neuron 1999;22:103-14. (Pubitemid 29070097)
26. Venables JP, Burn J. EASI - enrichment of alternatively spliced isoforms. Nucleic Acids Res 2006;34:e103.
27. Zacharias DA, Garamszegi N, Strehler EE. Characterization of persistent artifacts resulting from RT-PCR of alternatively spliced mRNAs. BioTechniques 1994;17:652-5. (Pubitemid 24313417)
28. Brinkman BM. Splice variants as cancer biomarkers. Clinical Biochem 2004;37:584-94. (Pubitemid 38845021)
29. Skotheim RI, Nees M. Alternative splicing in cancer: noise, functional, or systematic? Int J Biochem Cell Biol 2007;39:1432-49. (Pubitemid 47031033)
30. Clagett-Dame M, McNeill EM, Muley PD. Role of all-trans retinoic acid in neurite outgrowth and axonal elongation. J Neurobiol 2006;66:739-56. (Pubitemid 43939197)
31. Guilherme A, Soriano NA, Bose S, Holik J, Bose A, Pomerleau DP, et al. EHD2 and the novel EH domain binding protein EHBP1 couple endocytosis to the actin cytoskeleton. J Biol Chem 2004;279:10593-605. (Pubitemid 38372671)
32. Lu J, Meng W, Poy F, Maiti S, Goode BL, Eck MJ. Structure of the FH2 domain of Daam1: implications for formin regulation of actin assembly. J Mol Biol 2007;369:1258-69. (Pubitemid 46770768)
33. Matusek T, Gombos R, Szécsényi A, Sánchez-Soriano N, Czibula A, Pataki C, et al. Formin proteins of the DAAM subfamily play a role during axon growth. J Neurosci 2008;28:13310-9.
34. Yamashita M, Higashi T, Suetsugu S, Sato Y, Ikeda T, Shirakawa R, et al. Crystal structure of human DAAM1 formin homology 2 domain. Genes Cells 2007;12:1255-65. (Pubitemid 350042423)
35. Calarco JA, Superina S, O'Hanlon D, Gabut M, Raj B, Pan Q, et al. Regulation of vertebrate nervous system alternative splicing and development by an SR-related protein. Cell 2009;138:898-910.
36. Laura RP, Ross S, Koeppen H, Lasky LA. MAGI-1: a widely expressed, alternatively spliced tight junction protein. Exp CellRes 2002;275:155-70. (Pubitemid 34948359)
37. Howarth AG, Hughes MR, Stevenson BR. Detection of the tight junction-associated protein ZO-1 in astrocytes and other nonepithelial cell types. Am J Physiol 1992;262:C461-9.
38. Dobrosotskaya I, Guy RK, James GL. MAGI-1, a membrane-associated guanylate kinase with a unique arrangement of protein-protein interaction domains. J Biol Chem 1997;272:31589-97. (Pubitemid 28013302)
39. Gottardi CJ, Arpin M, Fanning AS, Louvard D. The junction-associated protein, zonula occludens-1, localizes to the nucleus before the maturation and during the remodeling of cell-cell contacts. Proc Natl Acad Sci U S A 1996;93:10779-84. (Pubitemid 26333066)
40. Strehler EE, Filoteo AG, Penniston JT, Caride AJ. Plasma-membrane Ca(2+) pumps: structural diversity as the basis for functional versatility. Biochem Soc Trans 2007;35:919-22.
41. Jensen KB, Dredge BK, Stefani G, Zhong R, Buckanovich RJ, Okano HJ, et al. Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability. Neuron 2000;25:359-71.
42. Murr R, Vaissiere T, Sawan C, Shukla V, Herceg Z. Orchestration of chromatin-based processes: mind the TRRAP. Oncogene 2007;26:5358-72. (Pubitemid 47260461)
43. Fazzio TG, Huff JT, Panning B. An RNAi screen of chromatin proteins identifies Tip60-p400 as a regulator of embryonic stem cell identity. Cell 2008;134:162-74. (Pubitemid 351905738)
44. Loizou JI, Oser G, Shukla V, Sawan C, Murr R, Wang ZQ, et al. Histone acetyltransferase cofactor Trrap is essential for maintaining the hematopoietic stem/progenitor cell pool. J Immunol 2009;183:6422-31.
45. Wurdak H, Zhu S, Romero A, Lorger M, Watson J, Chiang CY, et al. An RNAi screen identifies TRRAP as a regulator of brain tumor-initiating cell differentiation. Cell Stem Cell 2010;6:37-47.
46. Efimova EV, Al-Zoubi AM, Martinez O, Kaithamana S, Lu S, Arima T, et al. IG20, in contrast to DENN-SV, (MADD splice variants) suppresses tumor cell survival, and enhances their susceptibility to apoptosis and cancer drugs. Oncogene 2004;23:1076-87. (Pubitemid 38269961)
47. Mulherkar N, Ramaswamy M, Mordi DC, Prabhakar BS. MADD/DENN splice variant of the IG20 gene is necessary and sufficient for cancer cell survival. Oncogene 2006;25:6252-61. (Pubitemid 44564742)
48. Li LC, Sheng JR, Mulherkar N, Prabhakar BS, Meriggioli MN. Regulation of apoptosis and caspase-8 expression in neuroblastoma cells by isoforms of the IG20 gene. Cancer Res 2008;68:7352-61.
49. Boutz PL, Stoilov P, Li Q, Lin CH, Chawla G, Ostrow K, et al. A posttranscriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons. Genes Dev 2007;21:1636-52. (Pubitemid 47026368)
50. de la Grange P, Dutertre M, Correa M, Auboeuf D. A new advance in alternative splicing databases: from catalogue to detailed analysis of regulation of expression and function of human alternative splicing variants. BMC Bioinformatics 2007;8:180.